Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory factor X8 (RFX8) is a protein-coding gene encoding a predicted DNA-binding transcription factor implicated in regulation of transcription by RNA polymerase II[1][3][5][6][7]. RFX8 is a member of the RFX family of DNA-binding proteins, which are conserved across species and generally play roles in gene regulation, immune response, and development, though RFX8 itself remains poorly characterized compared to other RFX family members[1][2][4]. While other RFX proteins have established roles in immunity and disease, RFX8 has been associated with conditions including intracranial abscess and Williams-Beuren syndrome, but its direct functional or therapeutic relevance has not been established[1]. No drugs or therapeutic approaches specifically target RFX8, and no mechanisms of action, clinical biomarkers, or notable safety concerns are documented for this gene[1][3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory factor X8 (RFX8).